# US 2026/0062440 A1 · Multiplex Dye Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062440 A1
- Document ID: US20260062440A1
- Status: Published application
- Kind: A1
- Application number: 18/877,895
- Filed: 2023-06-29
- Published: 2026-03-05
- Earliest claimed: 2022-06-29
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Mohammad Mehdi Zahedi; Brian Evans; Khairuzzaman Bashar Mullah; Carmen Gjerstad; Mark Shannon; Harrison Leong
- Web page: https://patentgrep.com/patent/US20260062440A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- C07H 21/04: with deoxyribosyl as saccharide radical
- C09B 11/24: Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6851: Quantitative amplification
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)

## Abstract

Described herein, inter alia, are multiplex dye compounds and methods of use thereof.

## Claims

### Claim 1

An oligonucleotide, or a salt thereof, having the formula:
B is a divalent nucleobase;
L1 is a divalent linker L101-L102-L103-L104-L105; and
L101, L102, L103, L104, and L105 are independently a bond, —NH—, —O—, —S—, —S(O)—, —S(O)2—, —C(O)—, —C(O)NH—, —NHC(O)—, —NHC(O)NH—, —C(O)O—, —OC(O)—, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;
L5 is a divalent oligonucleotide linker comprising from 4 to 40 nucleotides;
L50 is a bond, —NH—, —O—, —S—, —S(O)—, —S(O)2—, —C(O)—, —C(O)NH—, —NHC(O)—, —NHC(O)NH—, —C(O)O—, —OC(O)—, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;
R50 is a detectable moiety selected from the group consisting of a monovalent form of FAM, a monovalent form of VIC, a monovalent form of ABY, a monovalent form of JUN, a monovalent form of AF647, a monovalent form of Cy5, a monovalent form of AF676, or a monovalent form of Cy5.5;
R30 is —OR30A;
R30A is hydrogen or a monovalent oligonucleotide moiety;
R2 is hydrogen or —OR2A;
R4 is hydrogen or unsubstituted methyl, or R2 and R4 substituents are joined to form a substituted or unsubstituted heterocycloalkyl;
R1 and R10 are independently hydrogen, —CCl3, —CBr3, —CF3, —CI3, —CHCl2, —CHBr2, —CHF2, —CHI2, —CH2Cl, —CH2Br, —CH2F, —CH2I, —CN, —OH, —NH2, —COOH, —CONH2, —OCCl3, —OCF3, —OCBr3, —OCI3, —OCHCl2, —OCHBr2, —OCHI2, —OCHF2, —OCH2Cl, —OCH2Br, —OCH2I, —OCH2F, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;
R6, R7, R8, and R9 are independently hydrogen, halogen, —CCl3, —CBr3, —CF3, —CI3, —CH2Cl, —CH2Br, —CH2F, —CH2I, —CHCl2, —CHBr2, —CHF2, —CHI2, —CN, —OH, —NH2, —COOH, —CONH2, —NO2, —SH, —SO3RA, —SO2NH2, —NHNH2, —ONH2, —NHC(O)NH2, —NHSO2H, —NHC(O)H, —NHC(O)OH, —NHOH, —OCCl3, —OCBr3, —OCF3, —OCI3, —OCH2Cl, —OCH2Br, —OCH2F, —OCH2I, —OCHCl2, —OCHBr2, —OCHF2, —OCHI2, —SF5, —N3, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
R1 and R6 may be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl;
R8 and R10 may be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and
R2A, R3A, R3B, R3C, and RA are independently hydrogen, —CCl3, —CBr3, —CF3, —CI3, —CHCl2, —CHBr2, —CHF2, —CHI2, —CH2Cl, —CH2Br, —CH2F, —CH2I, —CN, —OH, —NH2, —COOH, —CONH2, —OCCl3, —OCF3, —OCBr3, —OCI3, —OCHCl2, —OCHBr2, —OCHI2, —OCHF2, —OCH2Cl, —OCH2Br, —OCH2I, —OCH2F, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

### Claim 2 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 3 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 4 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 5 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 6 (depends on 1)

The oligonucleotide of claim 1, wherein B is a divalent cytosine or a derivative thereof, divalent guanine or a derivative thereof, divalent adenine or a derivative thereof, divalent thymine or a derivative thereof, divalent uracil or a derivative thereof, divalent hypoxanthine or a derivative thereof, divalent xanthine or a derivative thereof, divalent 7-methylguanine or a derivative thereof, divalent 5,6-dihydrouracil or a derivative thereof, divalent 5-methylcytosine or a derivative thereof, or divalent 5-hydroxymethylcytosine or a derivative thereof.

### Claim 7 (depends on 1)

The oligonucleotide of claim 1, wherein B is a divalent cytosine or a derivative thereof, divalent guanine or a derivative thereof, divalent adenine or a derivative thereof, divalent thymine or a derivative thereof, or divalent uracil or a derivative thereof.

### Claim 8 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 9 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 10 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 11 (depends on 1)

The oligonucleotide of claim 1, having the formula:

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The oligonucleotide of claim 1, wherein L5 comprises from 4 to 14 nucleotides.

### Claim 15 (depends on 1)

The oligonucleotide of claim 1, wherein L5 comprises from 6 to 12 nucleotides.

### Claim 16 (depends on 1)

The oligonucleotide of claim 1, wherein the nucleotides are DNA nucleotides.

### Claim 17 (depends on 1)

The oligonucleotide of claim 1, wherein the nucleotides are RNA nucleotides.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The oligonucleotide of claim 1, wherein L102 is an unsubstituted 3 to 8 membered heterocycloalkyl.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24 (depends on 1)

The oligonucleotide of claim 1, wherein L104 is an unsubstituted C1-C10 alkylene, unsubstituted 2 to 6 membered heteroalkylene, or unsubstituted phenylene.

### Claim 25

(canceled)

### Claim 26 (depends on 1)

The oligonucleotide of claim 1, wherein L105 is an unsubstituted C1-C10 alkylene, substituted or unsubstituted 2 to 8 membered heteroalkylene, or unsubstituted 5 to 10 membered heteroarylene.

### Claim 27 (depends on 1)

The oligonucleotide of claim 1, wherein L105 is

### Claim 28 (depends on 1)

The oligonucleotide of claim 1, wherein L1 is

### Claim at position 29

29-186. (canceled)
